Cardlytics (CDLX) Tops Q2 EPS by 32c, Offers Guidance

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.21), $0.32 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $35.6 million versus the consensus estimate of $34.84 million.

GUIDANCE:

Cardlytics sees Q3 2018 revenue of $36-38 million, versus the consensus of $37.85 million.

Cardlytics sees FY2018 revenue of $153-156 million, versus the consensus of $154.8 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Lennar Corp. (LEN) Misses Q2 EPS by 1c